Ad
related to: tricyclic antidepressants for fibromyalgia cancer patients symptoms problems- Still Depressed On Rx?
Your Antidepressant May Only Be
Partially Working. Learn More.
- Patient Tools & Resources
Get Helpful Tools
And Resources.
- Download Savings Card
Download Your Savings Card Today
for an Rx MDD Treatment.
- Doctor Conversation Guide
Ready To Talk To Your Doctor About
Your Symptoms? Download The Guide
- Still Depressed On Rx?
Search results
Results From The WOW.Com Content Network
Amitriptyline, sold under the brand name Elavil among others, is a tricyclic antidepressant primarily used to treat major depressive disorder, and a variety of pain syndromes such as neuropathic pain, fibromyalgia, migraine and tension headaches. [12]
Although two-thirds of patients will ultimately respond to antidepressant treatment, one-third of patients respond to placebo, [20] and remission is frequently sub-maximal (residual symptoms). In addition to post-treatment relapse, depressive symptoms can even recur in the course of long-term therapy ( tachyphylaxis ).
Fibromyalgia as a stand-alone diagnosis is uncommon, as most fibromyalgia patients often have other chronic overlapping pain problems or mental disorders. [11] Fibromyalgia is associated with mental health issues like anxiety , [ 51 ] posttraumatic stress disorder , [ 4 ] [ 51 ] bipolar disorder , [ 51 ] alexithymia , [ 52 ] and depression.
Despite their side effects, some tricyclic antidepressants may be effective for improving depression symptoms when other, newer medications aren’t effective. Atypical antidepressants.
The symptoms and the treatment of an overdose are generally the same as for the other tricyclic antidepressants, including anticholinergic effects, serotonin syndrome and adverse cardiac effects. TCAs, particularly nortriptyline, have a relatively narrow therapeutic index , which increase the chance of an overdose (both accidental and intentional).
Desipramine, sold under the brand name Norpramin among others, is a tricyclic antidepressant (TCA) used in the treatment of depression. [8] It acts as a relatively selective norepinephrine reuptake inhibitor, though it does also have other activities such as weak serotonin reuptake inhibitory, α 1-blocking, antihistamine, and anticholinergic effects.
The TCAs are used primarily in the clinical treatment of mood disorders such as major depressive disorder (MDD), dysthymia, and treatment-resistant variants. They are also used in the treatment of a number of other medical disorders, including cyclic vomiting syndrome (CVS) and anxiety disorders such as generalized anxiety disorder (GAD), social phobia (SP) also known as social anxiety ...
During its development for fibromyalgia, milnacipran was evaluated utilizing a composite responder approach.To be considered as a responder for the composite ‘treatment of fibromyalgia’ endpoint, each patient had to show concurrent and clinically meaningful improvements in pain, physical function, and global impression of disease status.